YORQINTA Trademark

Trademark Overview


On Tuesday, March 29, 2022, a trademark application was filed for YORQINTA with the United States Patent and Trademark Office. The USPTO has given the YORQINTA trademark a serial number of 97335626. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, September 4, 2024. This trademark is owned by Pfizer Inc.. The YORQINTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use
yorqinta

General Information


Serial Number97335626
Word MarkYORQINTA
Filing DateTuesday, March 29, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, April 1, 2022NEW APPLICATION ENTERED
Monday, April 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Wednesday, January 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 8, 2023SOU EXTENSION 1 FILED
Friday, September 8, 2023SOU EXTENSION 1 GRANTED
Tuesday, September 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 13, 2024SOU EXTENSION 2 GRANTED
Wednesday, March 13, 2024SOU EXTENSION 2 FILED
Thursday, March 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU EXTENSION 3 FILED
Wednesday, September 4, 2024SOU EXTENSION 3 GRANTED